These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15042690)

  • 1. Risk perception and concern among brothers of men with prostate carcinoma.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Chilson DM; Zuhlke KA; Claeys GB; Cooney KA
    Cancer; 2004 Apr; 100(7):1537-44. PubMed ID: 15042690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
    Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer.
    Vernon SW; Myers RE; Tilley BC; Li S
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):35-43. PubMed ID: 11205487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of race, age, income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer.
    Pruthi RS; Tornehl C; Gaston K; Lee K; Moore D; Carson CC; Wallen EM
    Eur Urol; 2006 Jul; 50(1):64-9. PubMed ID: 16364537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.
    Uzzo RG; Brown JG; Horwitz EM; Hanlon A; Mazzoni S; Konski A; Greenberg RE; Pollack A; Kolenko V; Watkins-Bruner D
    BJU Int; 2004 May; 93(7):955-60. PubMed ID: 15142142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
    Grönberg H; Wiklund F; Damber JE
    Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.
    McDowell ME; Occhipinti S; Gardiner RA; Baade PD; Steginga SK
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):545-55. PubMed ID: 19686273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening behavior in brothers and sons of men with prostate cancer.
    Cormier L; Reid K; Kwan L; Litwin MS
    J Urol; 2003 May; 169(5):1715-9. PubMed ID: 12686816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
    Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
    Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
    Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
    Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
    Hemminki K; Czene K
    Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory.
    Steginga SK; Pinnock C; Gardner M; Gardiner RA; Dunn J
    BJU Int; 2005 Jan; 95(1):46-50. PubMed ID: 15663527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening: knowledge, experiences and attitudes of men aged 40-79 years.
    Arroll B; Pandit S; Buetow S
    N Z Med J; 2003 Jun; 116(1176):U477. PubMed ID: 12835805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial aspects of prostate cancer: a case control study.
    Keetch DW; Rice JP; Suarez BK; Catalona WJ
    J Urol; 1995 Dec; 154(6):2100-2. PubMed ID: 7500468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
    Zeegers MP; Jellema A; Ostrer H
    Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for the symptomatic prostate cancer patient's delays in seeking care.
    Sunny L; Hopfgarten T; Adolfsson J; Steineck G
    Eur J Cancer; 2008 Mar; 44(5):733-9. PubMed ID: 18289844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.